CD19 and neoplasm: To confirm this, tumor cells obtained in 2/2 cases by flow sorting using CD19+CD103+CD11cHIgates achieved purities of 91.1–99.8%, and in these the tumor-derived IGHV marker gene was found in >98% of all clones examined in each case (data not shown).